Investors & Media

Stockholder Tools

Corporate Profile (Placeholder Template)

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Investor Overview

Common Stock

MGTX

Price

$123.45

Change (%)

+1.2 (0.84%)

Volume

123,456

Data as of: 04/10/18 3:18 p.m. ET. Refreshes every 15 minutes.

News Releases

View All
MARCH 2, 2018
MeiraGTx Receives EMA PRIME Designation for Achromatopsia Gene Therapy Candidate
View Article
FEBRUARY 1, 2018
MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene
View Article
DECEMBER 19, 2017
MeiraGTx Announces Gene Therapy Manufacturing Collaboration with Oxford Genetics
View Article

Investor Contact

John Doe
Title
Company

(123) 456-7890
mail@domain.com

Media Contact

John Doe
Title
Company

(123) 456-7890
mail@domain.com

Generic Content

Tables

Firstname Lastname Age
Jill Smith 50
Eve Jackson 94
Eve Jackson 94
Eve Jackson 94

Icons

HTML

PDF

DOC

SPREADSHEET

Lists

  • Item A
  • Item B
  • Item C
  1. Item 1
  2. Item 2
  3. Item 3